WW Share Price Performance
US$0
-33.54 (-100.00%)
Price US$0
Fair ValueUS$28.33
Share Pricen/a
Narrative Update • Jul 24
WW International, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
WW Community Narratives
AN
Fair Value
·Fair Value US$28.33 44.0% undervalued intrinsic discount
Long-Term GLP-1 Adoption And Integrated Care Will Reshape This Weight Management Subscription Business
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value US$35 54.7% undervalued intrinsic discount
GLP-1 Expansion And AI Platform Will Drive Long-Term Weight Health Leadership
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$20 20.7% undervalued intrinsic discount
GLP-1 Disruption And Declining Behavioral Subscribers Will Challenge Margins Yet Support Long-Term Opportunity
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
GLP-1 Disruption And Declining Behavioral Subscribers Will Challenge Margins Yet Support Long-Term Opportunity
Weight-loss drugs are reshaping how people manage their health, and WW International is racing to shift from its classic coaching model to a more medical, app-driven approach. The upside is a bigger pool of potential customers, but weaker sign-ups and tough competition could keep pressure on profits before any turnaround shows up.Read more
AN
US$20
20.7% undervalued intrinsic discount
Fair Value
Revenue
-3.76% p.a.
Profit Margin
12.09%
Future PE
3.81x
Price in 2029
US$28.33
GLP-1 Expansion And AI Platform Will Drive Long-Term Weight Health Leadership
WeightWatchers is trying to turn the rise of new weight-loss medicines into a comeback by pairing prescriptions with coaching and building a smarter app that keeps members engaged. The upside comes with real risks, from fierce competition in telehealth and medication access to the ongoing slide in its traditional program.Read more
AN
US$35
54.7% undervalued intrinsic discount
Fair Value
Revenue
-3.72% p.a.
Profit Margin
12.12%
Future PE
6.6x
Price in 2029
US$49.26
Long-Term GLP-1 Adoption And Integrated Care Will Reshape This Weight Management Subscription Business
WeightWatchers is betting that weight-loss drugs won’t replace its program but instead push more people toward a mix of medical care and long-term coaching through its clinic. The big question is whether that new growth can outrun the ongoing slide in its traditional memberships while competition and marketing costs heat up.Read more
AN
US$28.33
44.0% undervalued intrinsic discount
Fair Value
Revenue
-3.63% p.a.
Profit Margin
12.11%
Future PE
5.27x
Price in 2029
US$39.38
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
WW: Future GLP-1 And Medicare Push Will Drive Repricing
Fair Value: US$20 20.7% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
WW: Index Additions And Activist Pressure Will Unlock Future Upside
Fair Value: US$35 54.7% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
WW: Expanded Clinical Partnerships Will Drive Future Member And Earnings Strength
Fair Value: US$28.33 44.0% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
WW International, Inc. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -10.13
- 70.66%
- -15.22%
- 152.2%
About WW
- Founded
- 1963
- Employees
- 3500
- CEO
- WebsiteView website
WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause. The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for unlimited access to workshops; and Med+ subscription tier provides unlimited access to a clinician who can prescribe medications when clinically appropriate, including oral and injectable GLP 1s and hormone replacement therapy. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1963 and is headquartered in New York, New York.
Recent WW News & Updates
Narrative Update • Jul 10
